|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2010-5-28
|
|
pubmed:abstractText |
In approximately 20% of patients with superficial bladder tumors, the tumors progress to invasive tumors after treatment. Current methods of predicting the clinical behavior of these tumors prospectively are unreliable. We aim to identify a molecular signature that can reliably identify patients with high-risk superficial tumors that are likely to progress to invasive tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2660-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20421545-Adult,
pubmed-meshheading:20421545-Aged,
pubmed-meshheading:20421545-Aged, 80 and over,
pubmed-meshheading:20421545-Analysis of Variance,
pubmed-meshheading:20421545-Biopsy, Needle,
pubmed-meshheading:20421545-Carcinoma, Transitional Cell,
pubmed-meshheading:20421545-Cohort Studies,
pubmed-meshheading:20421545-Cystoscopy,
pubmed-meshheading:20421545-Disease Progression,
pubmed-meshheading:20421545-E2F2 Transcription Factor,
pubmed-meshheading:20421545-Female,
pubmed-meshheading:20421545-Gene Expression Profiling,
pubmed-meshheading:20421545-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20421545-Humans,
pubmed-meshheading:20421545-Immunohistochemistry,
pubmed-meshheading:20421545-Male,
pubmed-meshheading:20421545-Middle Aged,
pubmed-meshheading:20421545-Multivariate Analysis,
pubmed-meshheading:20421545-Neoplasm Invasiveness,
pubmed-meshheading:20421545-Neoplasm Staging,
pubmed-meshheading:20421545-Predictive Value of Tests,
pubmed-meshheading:20421545-Proportional Hazards Models,
pubmed-meshheading:20421545-RNA, Neoplasm,
pubmed-meshheading:20421545-Retrospective Studies,
pubmed-meshheading:20421545-Risk Assessment,
pubmed-meshheading:20421545-Survival Analysis,
pubmed-meshheading:20421545-Urinary Bladder Neoplasms,
pubmed-meshheading:20421545-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors.
|
|
pubmed:affiliation |
The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
